| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1080/14737175.2017.1259567 |
| P698 | PubMed publication ID | 27830959 |
| P2093 | author name string | Barış Ekici | |
| Burak Tatlı | |||
| Edibe Pembegül Yıldız | |||
| P2860 | cites work | Hypothermia reduces neurological damage in asphyxiated newborn infants | Q48467911 |
| Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy | Q48495331 | ||
| Antenatal magnesium sulphate neuroprotection in the preterm infant | Q48596637 | ||
| Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia | Q48598679 | ||
| Excitatory amino acids and magnesium sulfate in neonatal asphyxia. | Q48613622 | ||
| Erythropoietin reduces perihematomal inflammation and cell death with eNOS and STAT3 activations in experimental intracerebral hemorrhage | Q48617513 | ||
| Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells | Q48636873 | ||
| Effects of hypothermia for perinatal asphyxia on childhood outcomes | Q48669030 | ||
| Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells. | Q48671598 | ||
| Human cord blood transplantation in a neonatal rat model of hypoxic-ischemic brain damage: functional outcome related to neuroprotection in the striatum | Q48698472 | ||
| The role of neutrophils in the production of hypoxic-ischemic brain injury in the neonatal rat. | Q48722394 | ||
| Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy | Q48732854 | ||
| Post-ischemic modest hypothermia (35 degrees C) combined with intravenous magnesium is more effective at reducing CA1 neuronal death than either treatment used alone following global cerebral ischemia in rats | Q48902347 | ||
| Rewarming affects EEG background in term newborns with hypoxic-ischemic encephalopathy undergoing therapeutic hypothermia | Q49019037 | ||
| Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial | Q49032647 | ||
| Combined magnesium and mild hypothermia (35 degrees C) treatment reduces infarct volumes after permanent middle cerebral artery occlusion in the rat at 2 and 4, but not 6 h. | Q49053213 | ||
| Impairment of mitochondrial respiration after cerebral hypoxia-ischemia in immature rats: relationship to activation of caspase-3 and neuronal injury | Q49090197 | ||
| Long-term neuroprotective effects of allopurinol after moderate perinatal asphyxia: follow-up of two randomised controlled trials. | Q50992106 | ||
| Cord blood mononuclear cells prevent neuronal apoptosis in response to perinatal asphyxia in the newborn lamb. | Q52147223 | ||
| Effectiveness, tolerability, and safety of topiramate in children with partial-onset seizures. Topiramate YP Study Group. | Q53913823 | ||
| The protective role of melatonin in experimental hypoxic brain damage. | Q55041128 | ||
| Electrographic seizures are associated with brain injury in newborns undergoing therapeutic hypothermia | Q57954678 | ||
| Whole Body Hypothermia and Oxidative Stress in Babies With Hypoxic-Ischemic Brain Injury | Q58188413 | ||
| Childhood outcomes after hypothermia for neonatal encephalopathy | Q24633371 | ||
| Neuroprotective effect of melatonin: a novel therapy against perinatal hypoxia-ischemia | Q26999039 | ||
| A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine | Q29547303 | ||
| Effect of depth and duration of cooling on deaths in the NICU among neonates with hypoxic ischemic encephalopathy: a randomized clinical trial | Q30407953 | ||
| Risk factors for EEG seizures in neonates treated with hypothermia: a multicenter cohort study. | Q30577173 | ||
| Therapeutic hypothermia achieves neuroprotection via a decrease in acetylcholine with a concurrent increase in carnitine in the neonatal hypoxia-ischemia | Q30647907 | ||
| Effects of allopurinol and deferoxamine on reperfusion injury of the brain in newborn piglets after neonatal hypoxia-ischemia | Q30804951 | ||
| Hypoxic-ischemic encephalopathy: a review for the clinician | Q30893569 | ||
| Encephalopathy of prematurity includes neuronal abnormalities | Q30993427 | ||
| A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group | Q33328672 | ||
| Perivascular nitric oxide and superoxide in neonatal cerebral hypoxia-ischemia | Q33357269 | ||
| Experimental treatments for hypoxic ischaemic encephalopathy | Q33613301 | ||
| The use of hypothermia: a role in the treatment of neonatal asphyxia? | Q33700846 | ||
| Neuroprotective therapies after perinatal hypoxic-ischemic brain injury | Q33772042 | ||
| Cell therapy for neonatal hypoxia-ischemia and cerebral palsy | Q34269972 | ||
| Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network | Q34315813 | ||
| The mechanism of neuroprotection by topiramate in an animal model of epilepsy. | Q34372245 | ||
| Neuroprotection with prolonged head cooling started before postischemic seizures in fetal sheep | Q34477884 | ||
| Mild hypothermia combined with neural stem cell transplantation for hypoxic-ischemic encephalopathy: neuroprotective effects of combined therapy | Q34546178 | ||
| Postnatal erythropoietin treatment mitigates neural cell loss after systemic prenatal hypoxic-ischemic injury | Q34569855 | ||
| Pharmacological neuroprotection after perinatal hypoxic-ischemic brain injury | Q34829252 | ||
| Role of mitochondrial inner membrane permeabilization in necrotic cell death, apoptosis, and autophagy | Q35019114 | ||
| New antioxidant drugs for neonatal brain injury. | Q35037632 | ||
| Melatonin, longevity and health in the aged: an assessment | Q35074062 | ||
| Hypothermia augments neuroprotective activity of mesenchymal stem cells for neonatal hypoxic-ischemic encephalopathy | Q35224866 | ||
| Prevalence, causes, and outcome at 2 years of age of newborn encephalopathy: population based study | Q35296796 | ||
| Erythropoietin and hypothermia for hypoxic-ischemic encephalopathy | Q35471285 | ||
| How long is too long for cerebral cooling after ischemia in fetal sheep? | Q35572793 | ||
| Free radicals and their scavenging in stroke | Q35667198 | ||
| Hypoxia-ischemia in the immature brain | Q35857983 | ||
| Neuroprotective effect of simvastatin in stroke: a comparison between adult and neonatal rat models of cerebral ischemia. | Q36143481 | ||
| Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics | Q36277628 | ||
| Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis | Q36371706 | ||
| Topiramate and its clinical applications in epilepsy | Q36429751 | ||
| Melatonin: Nature's most versatile biological signal? | Q36525997 | ||
| Erythropoietin as a neuroprotectant for neonatal brain injury: animal models | Q36624171 | ||
| The inflammatory response in stroke | Q36692346 | ||
| Maturation-dependent vulnerability of perinatal white matter in premature birth | Q36721657 | ||
| Pathological apoptosis in the developing brain | Q36799186 | ||
| Destruction and reconstruction: hypoxia and the developing brain. | Q36982614 | ||
| Therapeutics for neonatal brain injury | Q37249164 | ||
| Stem cell therapy to protect and repair the developing brain: a review of mechanisms of action of cord blood and amnion epithelial derived cells | Q37251972 | ||
| Magnesium decreases inflammatory cytokine production: a novel innate immunomodulatory mechanism | Q37448003 | ||
| Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy | Q37710965 | ||
| Erythropoietin for neonatal brain injury: opportunity and challenge | Q37833284 | ||
| Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research | Q37880995 | ||
| Stem cells as promising therapeutic options for neurological disorders | Q38055452 | ||
| Hypothermia and xenon: novel noble guardians in hypoxic-ischemic encephalopathy? | Q38075513 | ||
| Magnesium for newborns with hypoxic-ischemic encephalopathy: a systematic review and meta-analysis | Q38112579 | ||
| Whole-body hypothermia for term and near-term newborns with hypoxic-ischemic encephalopathy: a randomized controlled trial | Q38492635 | ||
| Antenatal magnesium sulfate and neurodevelopmental outcome of preterm infants born to preeclamptic mothers | Q39016147 | ||
| Effects of moderate and deep hypothermia on RNA-binding proteins RBM3 and CIRP expressions in murine hippocampal brain slices | Q39193472 | ||
| Persisting mild hypothermia suppresses hypoxia-inducible factor-1alpha protein synthesis and hypoxia-inducible factor-1-mediated gene expression | Q39757114 | ||
| Neuronal damage after moderate hypoxia and erythropoietin | Q40413641 | ||
| Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. | Q41841220 | ||
| Stable insulin-secreting ducts formed by reprogramming of cells in the liver using a three-gene cocktail and a PPAR agonist. | Q41850316 | ||
| Hypothermia plus erythropoietin for neonatal neuroprotection? Commentary on Fan et al. and Fang et al | Q41918017 | ||
| Inflammation and NFkappaB activation is decreased by hypothermia following global cerebral ischemia. | Q42118480 | ||
| Inhibition of transition metal ion-catalysed ascorbate oxidation and lipid peroxidation by allopurinol and oxypurinol | Q42478240 | ||
| Topiramate pharmacokinetics in infants | Q42603610 | ||
| Oral topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia: a safety study | Q43018024 | ||
| The spectrum of abnormal neurologic outcomes subsequent to term intrapartum asphyxia | Q43237385 | ||
| Time is brain: starting therapeutic hypothermia within three hours after birth improves motor outcome in asphyxiated newborns | Q43525059 | ||
| Role of caspase-3 activation in cerebral ischemia-induced neurodegeneration in adult and neonatal brain | Q43937484 | ||
| Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model | Q44099805 | ||
| Can MRI related patient anxiety be prevented? | Q44216746 | ||
| Neuroprotective effect of N-acetylcysteine and hypothermia on the spinal cord ischemia-reperfusion injury | Q44575352 | ||
| Hypoxic-ischemic encephalopathy in preterm infants: antecedent factors, brain imaging, and outcome | Q44845637 | ||
| Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist | Q44864684 | ||
| Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke | Q44870573 | ||
| Therapeutic doses of topiramate are not toxic to the developing rat brain | Q44897078 | ||
| Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats | Q44922530 | ||
| N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain | Q45076521 | ||
| Topiramate pharmacokinetics in children with epilepsy aged from 6 months to 4 years | Q45127650 | ||
| Hypothermia and erythropoietin for neuroprotection after neonatal brain damage | Q45150227 | ||
| Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase | Q45269536 | ||
| Maternal allopurinol during fetal hypoxia lowers cord blood levels of the brain injury marker S-100B. | Q45947462 | ||
| Hypoxia-inducible factor 1alpha and erythropoietin upregulation with deferoxamine salvage after neonatal stroke. | Q45961886 | ||
| Patterns of brain injury in term neonatal encephalopathy. | Q46003823 | ||
| Expression of nitric oxide synthase isoforms and nitrotyrosine formation after hypoxia-ischemia in the neonatal rat brain | Q46660996 | ||
| Neuroprotective effect of long-term MgSO4 administration after cerebral hypoxia-ischemia in newborn rats is related to the severity of brain damage | Q46901882 | ||
| Cerebral hypothermia is not neuroprotective when started after postischemic seizures in fetal sheep | Q48121140 | ||
| A comparison of high-dose recombinant erythropoietin treatment regimens in brain-injured neonatal rats | Q48161042 | ||
| Selective head cooling with mild systemic hypothermia after neonatal hypoxic-ischemic encephalopathy: a multicenter randomized controlled trial in China | Q48191162 | ||
| Xenon mitigates isoflurane-induced neuronal apoptosis in the developing rodent brain | Q48214386 | ||
| Human recombinant erythropoietin in asphyxia neonatorum: pilot trial | Q48239234 | ||
| Hypoxic postconditioning reduces microglial activation, astrocyte and caspase activity, and inflammatory markers after hypoxia-ischemia in the neonatal rat brain. | Q48290925 | ||
| Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion | Q48304149 | ||
| How does xenon produce anaesthesia? | Q48332940 | ||
| Effect of allopurinol supplementation on nitric oxide levels in asphyxiated newborns | Q48340676 | ||
| Neurological and perceptual-motor outcome at 5 - 6 years of age in children with neonatal encephalopathy: relationship with neonatal brain MRI. | Q48405306 | ||
| Maternal allopurinol administration during suspected fetal hypoxia: a novel neuroprotective intervention? A multicentre randomised placebo controlled trial. | Q48410851 | ||
| Magnesium sulfate in severe perinatal asphyxia: a randomized, placebo-controlled trial | Q48437381 | ||
| Moderate hypothermia to treat perinatal asphyxial encephalopathy | Q48444657 | ||
| Melatonin use for neuroprotection in perinatal asphyxia: a randomized controlled pilot study | Q48457371 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypoxia | Q105688 |
| neonatal hypoxic-ischemic encephalopathy | Q5832339 | ||
| P304 | page(s) | 449-459 | |
| P577 | publication date | 2016-11-10 | |
| P1433 | published in | Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders | Q15760319 |
| P1476 | title | Neonatal hypoxic ischemic encephalopathy: an update on disease pathogenesis and treatment | |
| P478 | volume | 17 |
| Q41528807 | A Controversial Medicolegal Issue: Timing the Onset of Perinatal Hypoxic-Ischemic Brain Injury. |
| Q38612566 | Adjuvant treatment with monosialoganglioside may improve neurological outcomes in neonatal hypoxic-ischemic encephalopathy: A meta-analysis of randomized controlled trials |
| Q92535546 | An Assessment of Melatonin's Therapeutic Value in the Hypoxic-Ischemic Encephalopathy of the Newborn |
| Q91709720 | Application of a 3D pseudocontinuous arterial spin-labeled perfusion MRI scan combined with a postlabeling delay value in the diagnosis of neonatal hypoxic-ischemic encephalopathy |
| Q94460473 | COX5A over-expression protects cortical neurons from hypoxic ischemic injury in neonatal rats associated with TPI up-regulation |
| Q61799792 | Combined application of hypothermia and medical gases in cerebrovascular diseases |
| Q100559804 | Diffusion kurtosis imaging and pathological comparison of early hypoxic-ischemic brain damage in newborn piglets |
| Q99556322 | Efficacy of different treatment times of mild cerebral hypothermia on oxidative factors and neuroprotective effects in neonatal patients with moderate/severe hypoxic-ischemic encephalopathy |
| Q100455030 | Excess cerebral oxygen delivery follows return of spontaneous circulation in near-term asphyxiated lambs |
| Q64094061 | Haemodynamic Instability and Brain Injury in Neonates Exposed to Hypoxia⁻Ischaemia |
| Q64066241 | Melatonin as a master regulator of cell death and inflammation: molecular mechanisms and clinical implications for newborn care |
| Q47253527 | Mild hypothermia protects neurons against oxygen glucose deprivation via poly (ADP-ribose) signaling |
| Q53757262 | Neural stem cell therapies and hypoxic-ischemic brain injury. |
| Q47867738 | Neuroprotective Effect of Chitosan Oligosaccharide on Hypoxic-Ischemic Brain Damage in Neonatal Rats |
| Q125637259 | RETRACTED ARTICLE: F-box and WD repeat domain-containing 7 (FBXW7) mediates the hypoxia inducible factor-1α (HIF-1α)/vascular endothelial growth factor (VEGF) signaling pathway to affect hypoxic-ischemic brain damage in neonatal rats |
| Q89975533 | SIRT1 Mediates Melatonin's Effects on Microglial Activation in Hypoxia: In Vitro and In Vivo Evidence |
| Q47753171 | The Applicability of Amide Proton Transfer Imaging in the Nervous System: Focus on Hypoxic-Ischemic Encephalopathy in the Neonate. |
| Q90255667 | Vitamin D as an Adjuvant Therapy in Neonatal Hypoxia: Is it Beneficial? |
Search more.